Mednet Logo
HomeQuestion

How would you treat an isolated ipsilateral axillary recurrence in a BRCA+ HR+ HER2+ breast cancer?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Icahn School of Medicine at Mount Sinai

I would use olaparib for 12 months (OlympiA trial) in combination with endocrine therapy after surgery and radiation. Then continue the endocrine therapy with abemaciclib times 24 months and TDM1 for 12 months. Then only endocrine therapy for a total duration of 5-10 years. This is the most comprehe...

Register or Sign In to see full answer

How would you treat an isolated ipsilateral axillary recurrence in a BRCA+ HR+ HER2+ breast cancer? | Mednet